1. Academy of Pharmaceutical Sciences
John Wahlich, Jayne Lawrence, Eddie French

2. APS Mission and Aims Mission: Aims
Championing innovation and opportunity in Pharmaceutical Sciences for the delivery of medicines
Aims
Promote the Pharmaceutical Sciences to stakeholders
to facilitate understanding and achieve engagement
Share learning, drive collaboration, partnership and
innovation
Deliver insights into industry and academic roles for
emerging scientists

3. APS Strategic Themes
The mission of the Academy of Pharmaceutical Sciences is to champion innovation and opportunity in Pharmaceutical Sciences for the delivery of medicines.
Influence Policy
More investment in Pharm Sciences in UK
APS view sought by policy makers and TSB
APS recognised as only professional group representing Pharm Sciences
Senior Executives recognise the influence from and return on investment in APS
Promote Careers
Strengthen training and development of young scientists by supporting early career development
Build APS membership amongst students
Mentor post-grads and PhDs in academia
Establish connection with TSB for research projects
Further Scientific knowledge
Support Focus Groups to further scientific knowledge
Increase quantity of hard outputs/papers
Influence direction of research funding
Represent Pharma Sciences
Establish APS reputation for balanced independent view of Pharm Sciences in UK
Extend representation through engagement with pharma ‘mid tier’, CROs, CMOs and SMEs
Increase membership amongst pharma scientist population
APS Enablers
Increase organisational membership
Robust sponsorship income streams
Clear APS brand definition

4. Current Chairperson(s)
APS Focus Groups
Focus Group
Current Chairperson(s)
Emerging Scientists and Development
Helen Barker / Claire Thompson / Geoff Davison
Biomolecules and Vaccines
Kevin King
Biopharmaceutics and oral drug delivery
Mark McAllister
Inhalation
Eddie French
Material Sciences
Michael Leane
Pharmacognosy
Michael Heinrich
Process Engineering, Product Formulation and Manufacturing
Kendal Pitt
Anti-infectives (Microbiology)
Brendan Gilmore
Skin Forum
Majella Lane

5. APS
The APS is a not-for-profit organisation funded through membership and sponsorship
Of attendees today less than 25% are members of APS
If you like what we’re doing and want to support the Pharmaceutical Sciences in the UK join the APS!
£60 / year or £15 for students

6. Medicines for Older Adults
Meeting Stevenage 13 March 2013
Medicines for older adults: Learning from practice to develop patient centric drug products
Jointly organised by the Academy of Pharmaceutical Sciences (APS), the Geriatric Medicine Society and UCL School of Pharmacy
The event created the platform to discuss the provision of medicines for older adults from a pharmaceutical sciences perspective
Meeting commentary Int J Pharm Nov 1;456(1): doi: /j.ijpharm Epub 2013 Aug 3. (35 references)

7. Medicines for Older Adults
‘The use of medications in older patients is arguably the single most important health care intervention in the industrialized world’. (Avorn 2010)
Meeting discussed
Demographics of older adults
Physiological aspects of ageing
Medicines and ageing from a clinical, pharmacy and regulatory perspective
ADRs, polypharmacy, adherence, formulation and delivery aspects
Conclusion
Parallels with paediatric medicines
More could be done to improve the delivery of medicines to older adults
Opportunity for collaboration to achieve this
Avorn, J., Medication Use in Older Patients: Better Policy Could Encourage Better Practice. JAMA 304,

8. Age Related Medicines Focus Group
APS can provide the framework for collaboration
Web site
Access to membership and Linked-in contact networks
Links with other Focus Groups
Support (financial and organisational) for workshops / conferences / symposia
APS Pharm Sci 2014 Conference September
Potential for session at FIP Conference Bangkok (August 2014)
Outcome from meeting
Ownership going forward
Committee identified
Next steps agreed
It’s your meeting we’re here to facilitate!